Rhenman & Partners Asset Management AB
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 13, 2026), Rhenman & Partners Asset Management AB reported 99 stock positions worth $1.1 billion. Its top holding was Unitedhealth (UNH) at 3.7% of the portfolio, followed by CVS Health (CVS, 2.7%) and Astrazeneca (AZN, 2.7%). Compared with Q1 2026, it opened 20 new positions, sold out of 7, added to 41 and reduced 34. The biggest buy was a new position in Astrazeneca (AZN) and the biggest sale Boston Scientific (BSX, shares −28%).
- Most Recent 13F
- Q2 2026
- Location
- Stockholm, V7
- CIK
- 0001599882
- Portfolio Value
- $1.1B (Q2 2026)
- SEC Filing
- 0001213900-26-088652 ↗ filed Aug 13, 2026
Holdings Value
Holdings 99 stocks · $1.1B
| UNH Unitedhealth Group Inc. | 3.67% | 93,600 | $38.9M | Add +105.7% |
| CVS CVS Health Corp. | 2.73% | 279,374 | $28.9M | Reduce -17.0% |
| AZN Astrazeneca PLC | 2.69% | 151,500 | $28.5M | New |
| MRK Merck & Co. Inc. | 2.59% | 213,500 | $27.4M | New |
| LLY Eli Lilly & Co. | 2.53% | 22,315 | $26.8M | Reduce -33.8% |
| ABBV Abbvie Inc. | 2.30% | 96,775 | $24.4M | Add +35.2% |
| ALHC Alignment Healthcare Inc. | 2.24% | 997,083 | $23.7M | Reduce -5.3% |
| EW Edwards Lifesciences Corp. | 2.22% | 260,000 | $23.5M | Add +59.5% |
| GILD Gilead Sciences Inc. | 2.13% | 178,250 | $22.5M | Add +6.3% |
| JAZZ Jazz Pharmaceuticals PLC | 1.99% | 87,440 | $21.1M | Add +15.2% |
| BIIB Biogen Inc. | 1.93% | 94,850 | $20.5M | Reduce -13.1% |
| SYK Stryker Corp. | 1.93% | 65,000 | $20.5M | Add +36.0% |
| BSX Boston Scientific Corp. | 1.81% | 450,500 | $19.2M | Reduce -27.9% |
| JNJ Johnson & Johnson | 1.74% | 72,500 | $18.4M | New |
| GH Guardant Health Inc. | 1.63% | 115,000 | $17.3M | Reduce -20.7% |
| REGN Regeneron Pharmaceuticals | 1.61% | 27,390 | $17.1M | Reduce -43.1% |
| GKOS Glaukos Corp. | 1.57% | 119,000 | $16.6M | Add +41.7% |
| BMRN Biomarin Pharmaceutical Inc. | 1.57% | 290,500 | $16.6M | Add +40.3% |
| NRIX Nurix Therapeutics Inc. | 1.57% | 684,250 | $16.6M | Add +118.3% |
| NTRA Natera Inc. | 1.56% | 61,050 | $16.6M | Add +18.3% |
| MIRM Mirum Pharmaceuticals Inc. | 1.54% | 139,205 | $16.3M | Add +50.3% |
| INSM Insmed Inc. | 1.53% | 151,960 | $16.2M | Reduce -4.9% |
| THC Tenet Healthcare Corp. | 1.50% | 85,200 | $15.9M | Add +57.8% |
| TMO Thermo Fisher Scientific Inc. | 1.49% | 31,580 | $15.8M | Reduce -23.6% |
| CNC Centene Corp. | 1.48% | 244,000 | $15.7M | New |
| AXSM Axsome Therapeutics Inc. | 1.46% | 63,050 | $15.4M | Reduce -1.2% |
| DHR Danaher Corp. | 1.44% | 80,252 | $15.3M | Add +344.6% |
| VRTX Vertex Pharmaceuticals Inc. | 1.44% | 30,685 | $15.2M | Reduce -29.4% |
| AVR Anteris Technologies Global | 1.43% | 1,538,625 | $15.2M | Add +7.0% |
| NBIX Neurocrine Biosciences Inc. | 1.37% | 85,841 | $14.5M | Reduce -14.9% |
| PNTG The Pennant Group Inc. | 1.30% | 371,471 | $13.7M | Add +34.9% |
| ISRG Intuitive Surgical Inc. | 1.29% | 34,500 | $13.7M | Reduce -6.4% |
| ELV Elevance Health Inc. | 1.27% | 34,900 | $13.5M | Add +8.1% |
| LIVN Livanova PLC | 1.27% | 164,000 | $13.5M | Add +5.8% |
| COR Cencora Inc. | 1.25% | 46,778 | $13.2M | Reduce -10.7% |
| CRL Charles River Laboratories | 1.22% | 57,200 | $13.0M | Add +120.0% |
| IDYA Ideaya Biosciences Inc. | 1.21% | 343,800 | $12.8M | Add +34.6% |
| MCK McKesson Corp. | 1.18% | 16,550 | $12.5M | Reduce -1.8% |
| SNDX Syndax Pharmaceuticals Inc. | 1.16% | 560,250 | $12.2M | Add +47.7% |
| BTSG Brightspring Health Services | 1.09% | 165,896 | $11.6M | Add +231.8% |
| MDT Medtronic PLC | 1.07% | 145,000 | $11.3M | Add +61.1% |
| MLYS Mineralys Therapeutics Inc. | 1.06% | 416,371 | $11.2M | Add +58.3% |
| OSCR Oscar Health Inc. Class A | 1.06% | 392,000 | $11.2M | Reduce -40.6% |
| RPRX Royalty Pharma PLC Class A | 1.04% | 197,000 | $11.0M | Reduce -15.4% |
| DXCM Dexcom Inc. | 1.02% | 160,000 | $10.8M | New |
| ALGN Align Technology Inc. | 1.00% | 63,000 | $10.6M | Add +740.0% |
| SYRE Spyre Therapeutics Inc. | 1.00% | 119,300 | $10.6M | New |
| RLAY Relay Therapeutics Inc. | 1.00% | 566,000 | $10.6M | Add +57.2% |
| ARWR Arrowhead Pharmaceuticals Inc. | 0.98% | 128,000 | $10.4M | Reduce -11.4% |
| A Agilent Technologies Inc. | 0.94% | 75,000 | $10.0M | Add +200.0% |
| NKTR Nektar Therapeutics | 0.93% | 141,250 | $9.9M | Add +139.4% |
| ALKS Alkermes PLC | 0.92% | 185,250 | $9.7M | Add +39.0% |
| ABT Abbott Laboratories | 0.82% | 96,000 | $8.7M | Reduce -14.3% |
| DNTH Dianthus Therapeutics Inc. | 0.79% | 86,127 | $8.4M | Add +5.5% |
| PRCT Procept Biorobotics Corp. | 0.74% | 345,000 | $7.8M | Reduce -27.4% |
| GPCR Structure Therapeutics Inc. | 0.74% | 145,100 | $7.8M | Add +13.3% |
| ORKA Oruka Therapeutics Inc. | 0.72% | 80,000 | $7.6M | New |
| EHC Encompass Health Corp. | 0.71% | 74,263 | $7.5M | Add +32.0% |
| MLTX Moonlake Immunotherapeutics | 0.71% | 384,800 | $7.5M | Add +60.7% |
| IOVA Iovance Biotherapeutics Inc. | 0.67% | 1,705,327 | $7.1M | Reduce -17.0% |
| BBIO Bridgebio Pharma Inc. | 0.64% | 91,100 | $6.8M | Add +0.6% |
| KURA Kura Oncology Inc. | 0.61% | 591,500 | $6.5M | Add +117.9% |
| PODD Insulet Corp. | 0.60% | 42,000 | $6.4M | Add +200.0% |
| ERAS Erasca Inc. | 0.60% | 349,000 | $6.4M | New |
| KRYS Krystal Biotech Inc. | 0.57% | 16,325 | $6.1M | Reduce -2.1% |
| STVN Stevanato Group SPA | 0.52% | 305,972 | $5.5M | Add +11.4% |
| ASTH Astrana Health Inc. | 0.52% | 118,888 | $5.5M | New |
| CAH Cardinal Health Inc. | 0.50% | 22,500 | $5.3M | Reduce -16.7% |
| ALNY Alnylam Pharmaceuticals Inc. | 0.49% | 17,200 | $5.2M | Reduce -50.1% |
| MOH Molina Healthcare Inc. | 0.47% | 21,857 | $5.0M | New |
| VKTX Viking Therapeutics Inc. | 0.47% | 128,000 | $5.0M | Reduce -20.0% |
| CI The Cigna Group | 0.45% | 17,400 | $4.8M | Add +117.5% |
| IONS Ionis Pharmaceuticals Inc. | 0.45% | 59,900 | $4.7M | Reduce -35.5% |
| AMN Amn Healthcare Services Inc. | 0.44% | 144,466 | $4.7M | New |
| DNLI Denali Therapeutics Inc. | 0.43% | 179,000 | $4.6M | Reduce -10.1% |
| MEDP Medpace Holdings Inc. | 0.42% | 8,500 | $4.5M | New |
| MDGL Madrigal Pharmaceuticals Inc. | 0.41% | 8,050 | $4.3M | Reduce -66.5% |
| AMGN Amgen Inc. | 0.41% | 11,900 | $4.3M | Reduce -21.7% |
| SION Sionna Therapeutics Inc. | 0.40% | 97,100 | $4.3M | Add +11.0% |
| ASND Ascendis Pharma A/S | 0.38% | 15,000 | $4.0M | No change |
| COO The Cooper Cos Inc. | 0.37% | 54,000 | $3.9M | Add +8.0% |
| WAY Waystar Holding Corp. | 0.35% | 178,566 | $3.7M | Reduce -47.9% |
| MBX MBX Biosciences Inc. | 0.32% | 62,000 | $3.4M | New |
| VCEL Vericel Corp. | 0.29% | 70,000 | $3.1M | No change |
| VEEV Veeva Systems Inc. Class A | 0.29% | 17,300 | $3.1M | Reduce -79.7% |
| BCAX Bicara Therapeutics Inc. | 0.25% | 88,150 | $2.6M | New |
| STE Steris PLC | 0.23% | 11,500 | $2.4M | No change |
| OCUL Ocular Therapeutix Inc. | 0.21% | 225,000 | $2.2M | Reduce -26.2% |
| STOK Stoke Therapeutics Inc. | 0.20% | 64,500 | $2.1M | Reduce -22.3% |
| XENE Xenon Pharmaceuticals Inc. | 0.19% | 33,250 | $2.0M | Add +18.8% |
| DOCS Doximity Inc. Class A | 0.15% | 76,107 | $1.6M | Reduce -58.6% |
| PRVA Privia Health Group Inc. | 0.12% | 50,000 | $1.3M | New |
| NVCR Novocure Ltd. | 0.10% | 70,000 | $1.1M | No change |
| MMED Minimed Group Inc. | 0.08% | 55,000 | $822K | New |
| ATEC Alphatec Holdings Inc. | 0.07% | 85,000 | $735K | Add +21.4% |
| AGL Agilon Health Inc. | 0.05% | 5,000 | $536K | New |
| TXG 10X Genomics Inc. Class A | 0.03% | 8,500 | $326K | New |
| TNDM Tandem Diabetes Care Inc. | 0.03% | 20,000 | $302K | New |
| TGTX TG Therapeutics Inc. | 0.03% | 5,000 | $275K | New |
Portfolio Sells Q1 2026 → Q2 2026
| BSX Boston Scientific Corp. | Reduce -27.9% | 1.81% | −3.02 |
| REGN Regeneron Pharmaceuticals | Reduce -43.1% | 1.61% | −2.97 |
| INSM Insmed Inc. | Reduce -4.9% | 1.53% | −1.69 |
| VEEV Veeva Systems Inc. Class A | Reduce -79.7% | 0.29% | −1.56 |
| LLY Eli Lilly & Co. | Reduce -33.8% | 2.53% | −1.30 |
| ADPT Adaptive Biotechnologies | Sold out | 0.00% | −1.23 |
| MDGL Madrigal Pharmaceuticals Inc. | Reduce -66.5% | 0.41% | −1.15 |
| IQV Iqvia Holdings Inc. | Sold out | 0.00% | −1.12 |
| NUVL Nuvalent Inc. Class A | Sold out | 0.00% | −1.03 |
| TMO Thermo Fisher Scientific Inc. | Reduce -23.6% | 1.49% | −1.01 |
| VRTX Vertex Pharmaceuticals Inc. | Reduce -29.4% | 1.44% | −0.96 |
| ALNY Alnylam Pharmaceuticals Inc. | Reduce -50.1% | 0.49% | −0.92 |
| ISRG Intuitive Surgical Inc. | Reduce -6.4% | 1.29% | −0.80 |
| COR Cencora Inc. | Reduce -10.7% | 1.25% | −0.78 |
| APGE Apogee Therapeutics Inc. | Sold out | 0.00% | −0.78 |
| PRCT Procept Biorobotics Corp. | Reduce -27.4% | 0.74% | −0.73 |
| WAY Waystar Holding Corp. | Reduce -47.9% | 0.35% | −0.67 |
| MCK McKesson Corp. | Reduce -1.8% | 1.18% | −0.62 |
| ABT Abbott Laboratories | Reduce -14.3% | 0.82% | −0.60 |
| BIIB Biogen Inc. | Reduce -13.1% | 1.93% | −0.53 |
| IONS Ionis Pharmaceuticals Inc. | Reduce -35.5% | 0.45% | −0.41 |
| DOCS Doximity Inc. Class A | Reduce -58.6% | 0.15% | −0.38 |
| RPRX Royalty Pharma PLC Class A | Reduce -15.4% | 1.04% | −0.34 |
| ESPR Esperion Therapeutics Inc. | Sold out | 0.00% | −0.33 |
| IMCR Immunocore Holdings PLC-ADR | Sold out | 0.00% | −0.32 |
| NBIX Neurocrine Biosciences Inc. | Reduce -14.9% | 1.37% | −0.27 |
| CVS CVS Health Corp. | Reduce -17.0% | 2.73% | −0.25 |
| AMGN Amgen Inc. | Reduce -21.7% | 0.41% | −0.25 |
| IOVA Iovance Biotherapeutics Inc. | Reduce -17.0% | 0.67% | −0.22 |
| CAH Cardinal Health Inc. | Reduce -16.7% | 0.50% | −0.20 |
| VKTX Viking Therapeutics Inc. | Reduce -20.0% | 0.47% | −0.17 |
| STOK Stoke Therapeutics Inc. | Reduce -22.3% | 0.20% | −0.13 |
| ARWR Arrowhead Pharmaceuticals Inc. | Reduce -11.4% | 0.98% | −0.13 |
| OCUL Ocular Therapeutix Inc. | Reduce -26.2% | 0.21% | −0.11 |
| CMPX Compass Therapeutics Inc. | Sold out | 0.00% | −0.08 |
| ALHC Alignment Healthcare Inc. | Reduce -5.3% | 2.24% | −0.05 |
| DNLI Denali Therapeutics Inc. | Reduce -10.1% | 0.43% | −0.04 |
| GH Guardant Health Inc. | Reduce -20.7% | 1.63% | −0.02 |
| KRYS Krystal Biotech Inc. | Reduce -2.1% | 0.57% | +0.04 |
| OSCR Oscar Health Inc. Class A | Reduce -40.6% | 1.06% | +0.12 |
| AXSM Axsome Therapeutics Inc. | Reduce -1.2% | 1.46% | +0.13 |
Portfolio Buys Q1 2026 → Q2 2026
| AZN Astrazeneca PLC | New | 2.69% | +2.69 |
| MRK Merck & Co. Inc. | New | 2.59% | +2.59 |
| UNH Unitedhealth Group Inc. | Add +105.7% | 3.67% | +2.15 |
| JNJ Johnson & Johnson | New | 1.74% | +1.74 |
| CNC Centene Corp. | New | 1.48% | +1.48 |
| DHR Danaher Corp. | Add +344.6% | 1.44% | +1.02 |
| DXCM Dexcom Inc. | New | 1.02% | +1.02 |
| SYRE Spyre Therapeutics Inc. | New | 1.00% | +1.00 |
| NRIX Nurix Therapeutics Inc. | Add +118.3% | 1.57% | +0.97 |
| ALGN Align Technology Inc. | Add +740.0% | 1.00% | +0.84 |
| BTSG Brightspring Health Services | Add +231.8% | 1.09% | +0.83 |
| ORKA Oruka Therapeutics Inc. | New | 0.72% | +0.72 |
| CRL Charles River Laboratories | Add +120.0% | 1.22% | +0.67 |
| EW Edwards Lifesciences Corp. | Add +59.5% | 2.22% | +0.61 |
| ERAS Erasca Inc. | New | 0.60% | +0.60 |
| A Agilent Technologies Inc. | Add +200.0% | 0.94% | +0.59 |
| RLAY Relay Therapeutics Inc. | Add +57.2% | 1.00% | +0.56 |
| ASTH Astrana Health Inc. | New | 0.52% | +0.52 |
| MIRM Mirum Pharmaceuticals Inc. | Add +50.3% | 1.54% | +0.48 |
| MOH Molina Healthcare Inc. | New | 0.47% | +0.47 |
| GKOS Glaukos Corp. | Add +41.7% | 1.57% | +0.45 |
| AVR Anteris Technologies Global | Add +7.0% | 1.43% | +0.45 |
| AMN Amn Healthcare Services Inc. | New | 0.44% | +0.44 |
| MEDP Medpace Holdings Inc. | New | 0.42% | +0.42 |
| NKTR Nektar Therapeutics | Add +139.4% | 0.93% | +0.41 |
| ABBV Abbvie Inc. | Add +35.2% | 2.30% | +0.38 |
| KURA Kura Oncology Inc. | Add +117.9% | 0.61% | +0.34 |
| ALKS Alkermes PLC | Add +39.0% | 0.92% | +0.33 |
| MBX MBX Biosciences Inc. | New | 0.32% | +0.32 |
| NTRA Natera Inc. | Add +18.3% | 1.56% | +0.29 |
| PNTG The Pennant Group Inc. | Add +34.9% | 1.30% | +0.26 |
| THC Tenet Healthcare Corp. | Add +57.8% | 1.50% | +0.25 |
| BCAX Bicara Therapeutics Inc. | New | 0.25% | +0.25 |
| PODD Insulet Corp. | Add +200.0% | 0.60% | +0.24 |
| JAZZ Jazz Pharmaceuticals PLC | Add +15.2% | 1.99% | +0.22 |
| CI The Cigna Group | Add +117.5% | 0.45% | +0.19 |
| MLYS Mineralys Therapeutics Inc. | Add +58.3% | 1.06% | +0.18 |
| IDYA Ideaya Biosciences Inc. | Add +34.6% | 1.21% | +0.16 |
| MLTX Moonlake Immunotherapeutics | Add +60.7% | 0.71% | +0.16 |
| BMRN Biomarin Pharmaceutical Inc. | Add +40.3% | 1.57% | +0.13 |
| PRVA Privia Health Group Inc. | New | 0.12% | +0.12 |
| MDT Medtronic PLC | Add +61.1% | 1.07% | +0.11 |
| ELV Elevance Health Inc. | Add +8.1% | 1.27% | +0.11 |
| MMED Minimed Group Inc. | New | 0.08% | +0.08 |
| SNDX Syndax Pharmaceuticals Inc. | Add +47.7% | 1.16% | +0.06 |
| LIVN Livanova PLC | Add +5.8% | 1.27% | +0.06 |
| STVN Stevanato Group SPA | Add +11.4% | 0.52% | +0.06 |
| AGL Agilon Health Inc. | New | 0.05% | +0.05 |
| EHC Encompass Health Corp. | Add +32.0% | 0.71% | +0.04 |
| TXG 10X Genomics Inc. Class A | New | 0.03% | +0.03 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 99 | $1.1B | UNH, CVS, AZN, MRK, LLY |
| Q1 2026 | 86 | $810.5M | BSX, REGN, LLY, INSM, CVS |
| Q4 2025 | 94 | $1.1B | REGN, LLY, BSX, MDT, ISRG |
| Q3 2025 | 92 | $903.7M | BSX, LLY, ABBV, DHR, ALHC |
| Q2 2025 | 90 | $791.0M | LLY, BSX, VRTX, GKOS, ISRG |
| Q1 2025 | 94 | $870.0M | UNH, LLY, VRTX, MCK, BSX |
| Q4 2024 | 92 | $972.9M | BSX, LLY, PRCT, ISRG, REGN |
| Q3 2024 | 95 | $1.2B | BSX, UNH, LLY, REGN, THC |
| Q2 2024 | 93 | $1.0B | UNH, ELV, BSX, LLY, REGN |
| Q1 2024 | 84 | $1.1B | CI, LLY, THC, BSX, ELV |